The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective

BACKGROUND: Nephrotic syndrome is a disorder characterized by proteinuria, hypoalbuminemia and dyslipidemia. Low-dose alternate-day steroid regimen is the standard of care. In case of relapse or significant adverse events, steroid-sparing agents may be used. This analysis was aimed at assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Maratea, Dario, Bettio, Monica, Corti, Maria Grazia, Montini, Giovanni, Venturini, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943005/
https://www.ncbi.nlm.nih.gov/pubmed/27405390
http://dx.doi.org/10.1186/s13052-016-0271-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943005/
https://www.ncbi.nlm.nih.gov/pubmed/27405390
http://dx.doi.org/10.1186/s13052-016-0271-6

Ejemplares similares